Working Group Leads
Dan Barouch, M.D., Ph.D.
Professor of Medicine, HMS
Director of the Center for Virology and Vaccine Research, BIDMC
Member, Ragon Institute of MGH, MIT, and Harvard
Andrea Carfi, Ph.D.
Head of Research, Infectious Disease, Moderna
Vaccines Working Group
The Vaccines Working Group was created to support research, design and development of vaccines against COVID-19. The group meets every two weeks to discuss the latest advances in immunology, virology, vaccine science, epidemiology, vaccine development, regulatory approvals and distribution. Current areas of focus of the Vaccine Working Group include understanding the longevity of vaccine-induced immunity, biological correlates of immunity, issues related to SARS-CoV-2 infection among vaccinated individuals including the impact of viral variants, and the ethical, structural and social-political dimensions of the COVID-19 vaccines such as vaccine trial design, recruitment and participation, vaccine access, distribution, vaccine equity and acceptance.
Members of the Vaccines Working Group played an important role in the development and testing of two COVID-19 vaccines, now approved for Emergency Use Authorization by the United States Food and Drug Administration: Harvard Medical School and MassCPR member Lindsey Baden was one of the clinical investigators who oversaw the clinical trials of Moderna’s mRNA-based vaccine; MassCPR member and HMS professor Dan Barouch conducted the foundational research that enabled the design and subsequent development of the Johnson & Johnson “one-shot” Ad26 adenovirus-based vaccine. The approval and deployment of these two vaccines, along with other COVID-19 vaccines, have been among the most important tools in combating the pandemic.
To join the Vaccines Working Group, please fill out this form.